ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

NAS To Honor Outstanding Scientists

February 28, 1997

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Hopkins, Pennsylvania Ok’d As Comprehensive; No. Remains At 24

May 24, 1991

ASCO Updates Guideline On Antiemetics

June 30, 2006